CureVac N.V. (CVAC)
Jan 6, 2026 - CVAC was delisted (reason: acquired by BNTX)
4.660
-0.010 (-0.21%)
Inactive · Last trade price on Jan 5, 2026

CureVac Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for CureVac stock had an average target of $6.83, with a low estimate of $5.00 and a high estimate of $10.

Price Target: $6.83 (+46.57%)
Analyst Consensus: Hold

Price Target

TargetLowAverageMedianHigh
Price$5.00$6.83n/a$10
Change+7.30%+46.57%n/a+114.59%

Analyst Ratings

The average analyst rating for CureVac stock from 3 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.

Recommendation Trends

No data available
RatingOct 2026
Strong Buyn/a
Buyn/a
Holdn/a
Selln/a
Strong Selln/a
Totaln/a

Financial Forecast

Revenue This Year
72.69M
from 535.18M
Decreased by -86.42%
Revenue Next Year
89.92M
from 72.69M
Increased by 23.71%
EPS This Year
-0.47
from 0.72
EPS Next Year
-0.44
from -0.47
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
48.87M102.99M67.42M53.76M535.18M72.69M89.92M
Revenue Growth
180.61%110.74%-34.54%-20.26%895.54%-86.42%23.71%
EPS
-0.98-2.21-1.32-1.180.72-0.47-0.44
No. Analysts
-----77
Financial currency is EUR.

Revenue Forecast

Revenue202520262027202820292030
High110.3M111.3M
Avg72.7M89.9M
Low33.5M60.0M

Revenue Growth

Revenue Growth202520262027202820292030
High
-79.4%
53.1%
Avg
-86.4%
23.7%
Low
-93.7%
-17.5%

EPS Forecast

EPS202520262027
High-0.13-0.16
Avg-0.47-0.44
Low-0.70-0.72

EPS Growth

EPS Growth202520262027
High--
Avg--
Low--